Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Defibrillators, Implantable | 14 | 2016 | 190 | 1.760 |
Why?
|
| Cardiac Pacing, Artificial | 8 | 2012 | 119 | 1.310 |
Why?
|
| Sarcoidosis | 6 | 2016 | 98 | 1.130 |
Why?
|
| Pacemaker, Artificial | 7 | 2013 | 116 | 1.040 |
Why?
|
| Electrodes, Implanted | 4 | 2013 | 222 | 0.860 |
Why?
|
| Arrhythmias, Cardiac | 5 | 2014 | 233 | 0.850 |
Why?
|
| Heart Failure | 11 | 2018 | 1438 | 0.800 |
Why?
|
| Cardiomyopathies | 4 | 2016 | 318 | 0.770 |
Why?
|
| Long QT Syndrome | 2 | 2016 | 41 | 0.570 |
Why?
|
| Ventricular Dysfunction, Left | 6 | 2015 | 346 | 0.560 |
Why?
|
| Cardiac Resynchronization Therapy | 6 | 2018 | 89 | 0.550 |
Why?
|
| Equipment Failure Analysis | 5 | 2013 | 93 | 0.520 |
Why?
|
| Ventricular Fibrillation | 2 | 2013 | 78 | 0.470 |
Why?
|
| Gadolinium | 1 | 2014 | 106 | 0.400 |
Why?
|
| Kidney Function Tests | 1 | 2013 | 116 | 0.400 |
Why?
|
| Coronary Angiography | 1 | 2013 | 262 | 0.370 |
Why?
|
| Echocardiography | 5 | 2016 | 1010 | 0.350 |
Why?
|
| Electrocardiography | 8 | 2016 | 559 | 0.330 |
Why?
|
| Atrial Fibrillation | 7 | 2015 | 444 | 0.320 |
Why?
|
| Acute Kidney Injury | 1 | 2013 | 341 | 0.300 |
Why?
|
| Ultrasonography, Doppler | 1 | 2009 | 83 | 0.300 |
Why?
|
| Safety | 1 | 2009 | 147 | 0.290 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 395 | 0.290 |
Why?
|
| Cardiac Electrophysiology | 1 | 2008 | 11 | 0.290 |
Why?
|
| Catheter Ablation | 4 | 2016 | 365 | 0.270 |
Why?
|
| Tachycardia, Ventricular | 3 | 2016 | 180 | 0.270 |
Why?
|
| Electric Countershock | 3 | 2016 | 77 | 0.260 |
Why?
|
| Ventricular Function, Left | 4 | 2016 | 677 | 0.260 |
Why?
|
| Bundle-Branch Block | 1 | 2007 | 66 | 0.250 |
Why?
|
| Quality of Life | 4 | 2016 | 1816 | 0.230 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 3642 | 0.230 |
Why?
|
| Humans | 39 | 2018 | 95992 | 0.220 |
Why?
|
| Middle Aged | 18 | 2016 | 28299 | 0.210 |
Why?
|
| Heart Ventricles | 1 | 2009 | 826 | 0.210 |
Why?
|
| Male | 26 | 2018 | 45792 | 0.200 |
Why?
|
| Female | 23 | 2018 | 49980 | 0.200 |
Why?
|
| Prevalence | 4 | 2016 | 1355 | 0.180 |
Why?
|
| Heart Diseases | 2 | 2016 | 318 | 0.180 |
Why?
|
| Stroke Volume | 6 | 2016 | 550 | 0.160 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 2 | 2016 | 20 | 0.150 |
Why?
|
| Risk Assessment | 3 | 2016 | 2498 | 0.150 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2018 | 19 | 0.150 |
Why?
|
| Prognosis | 6 | 2018 | 3993 | 0.140 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2018 | 48 | 0.140 |
Why?
|
| Equipment Design | 5 | 2016 | 435 | 0.140 |
Why?
|
| Equipment Failure | 4 | 2012 | 133 | 0.140 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 206 | 0.130 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2010 | 50 | 0.130 |
Why?
|
| Heart Failure, Systolic | 1 | 2016 | 6 | 0.120 |
Why?
|
| Treatment Outcome | 11 | 2016 | 9228 | 0.120 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2014 | 82 | 0.120 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2016 | 59 | 0.120 |
Why?
|
| Adult | 10 | 2016 | 28636 | 0.120 |
Why?
|
| Heart Rate | 2 | 2016 | 533 | 0.110 |
Why?
|
| Health Care Costs | 1 | 2016 | 255 | 0.110 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2014 | 31 | 0.100 |
Why?
|
| Differential Threshold | 1 | 2013 | 13 | 0.100 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2016 | 700 | 0.100 |
Why?
|
| Hospitalization | 2 | 2016 | 946 | 0.100 |
Why?
|
| Causality | 1 | 2013 | 84 | 0.100 |
Why?
|
| Image Enhancement | 1 | 2016 | 565 | 0.100 |
Why?
|
| Sex Factors | 1 | 2016 | 1130 | 0.100 |
Why?
|
| Anesthesiology | 1 | 2015 | 168 | 0.100 |
Why?
|
| Cardiology | 1 | 2014 | 134 | 0.100 |
Why?
|
| Aged | 10 | 2018 | 20927 | 0.090 |
Why?
|
| Quality Assurance, Health Care | 1 | 2014 | 231 | 0.090 |
Why?
|
| Retrospective Studies | 6 | 2016 | 10307 | 0.090 |
Why?
|
| Consensus | 1 | 2014 | 372 | 0.090 |
Why?
|
| Oxygen Consumption | 2 | 2015 | 253 | 0.090 |
Why?
|
| Systole | 1 | 2011 | 118 | 0.090 |
Why?
|
| Prosthesis Design | 2 | 2013 | 311 | 0.080 |
Why?
|
| Acetanilides | 1 | 2010 | 6 | 0.080 |
Why?
|
| Syndactyly | 1 | 2010 | 13 | 0.080 |
Why?
|
| Brugada Syndrome | 1 | 2010 | 15 | 0.080 |
Why?
|
| Ventricular Septum | 1 | 2010 | 16 | 0.080 |
Why?
|
| Ventricular Remodeling | 2 | 2009 | 114 | 0.080 |
Why?
|
| Anticoagulants | 1 | 2014 | 465 | 0.080 |
Why?
|
| Radiography, Thoracic | 1 | 2012 | 333 | 0.080 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2010 | 36 | 0.080 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2010 | 81 | 0.080 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2011 | 173 | 0.080 |
Why?
|
| Societies, Medical | 1 | 2014 | 645 | 0.080 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2015 | 519 | 0.080 |
Why?
|
| Primary Prevention | 1 | 2010 | 87 | 0.080 |
Why?
|
| Punctures | 1 | 2009 | 29 | 0.080 |
Why?
|
| Comorbidity | 1 | 2013 | 1017 | 0.080 |
Why?
|
| Needles | 1 | 2009 | 42 | 0.080 |
Why?
|
| Heart Septum | 1 | 2009 | 51 | 0.080 |
Why?
|
| Incidence | 1 | 2013 | 1723 | 0.070 |
Why?
|
| Silicone Elastomers | 1 | 2008 | 8 | 0.070 |
Why?
|
| Polyurethanes | 1 | 2008 | 13 | 0.070 |
Why?
|
| Chicago | 1 | 2013 | 1505 | 0.070 |
Why?
|
| Electrocoagulation | 1 | 2008 | 22 | 0.070 |
Why?
|
| Piperazines | 1 | 2010 | 296 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 1618 | 0.070 |
Why?
|
| Myocardium | 1 | 2011 | 606 | 0.070 |
Why?
|
| Hot Temperature | 1 | 2008 | 221 | 0.070 |
Why?
|
| Medicare | 1 | 2011 | 458 | 0.070 |
Why?
|
| Treatment Failure | 1 | 2007 | 297 | 0.060 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2007 | 107 | 0.060 |
Why?
|
| Cross-Over Studies | 1 | 2007 | 398 | 0.060 |
Why?
|
| Electrophysiology | 1 | 2007 | 408 | 0.060 |
Why?
|
| Risk Factors | 3 | 2013 | 5992 | 0.060 |
Why?
|
| Echocardiography, Doppler | 1 | 2007 | 193 | 0.060 |
Why?
|
| Heart Conduction System | 1 | 2007 | 140 | 0.060 |
Why?
|
| Hyperlipidemias | 1 | 2006 | 91 | 0.060 |
Why?
|
| Body Height | 1 | 2006 | 108 | 0.060 |
Why?
|
| Hypolipidemic Agents | 1 | 2006 | 99 | 0.060 |
Why?
|
| Heart-Assist Devices | 1 | 2013 | 903 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 7224 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2007 | 890 | 0.060 |
Why?
|
| Renal Insufficiency | 1 | 2006 | 99 | 0.060 |
Why?
|
| Stroke | 1 | 2014 | 1089 | 0.050 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2009 | 528 | 0.050 |
Why?
|
| Research Design | 1 | 2007 | 630 | 0.050 |
Why?
|
| Surgical Wound Infection | 1 | 2006 | 237 | 0.050 |
Why?
|
| Heart Block | 1 | 2003 | 37 | 0.050 |
Why?
|
| Cardiac Imaging Techniques | 2 | 2012 | 26 | 0.050 |
Why?
|
| Decision Support Techniques | 2 | 2016 | 186 | 0.050 |
Why?
|
| Exercise Test | 2 | 2015 | 179 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 2 | 2016 | 500 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 935 | 0.040 |
Why?
|
| Atrial Flutter | 1 | 2001 | 42 | 0.040 |
Why?
|
| Time Factors | 3 | 2016 | 5593 | 0.040 |
Why?
|
| Monitoring, Physiologic | 2 | 2012 | 273 | 0.040 |
Why?
|
| Coronary Disease | 1 | 2001 | 263 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 1819 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2001 | 252 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2018 | 318 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2885 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2016 | 39 | 0.030 |
Why?
|
| Device Approval | 1 | 2016 | 14 | 0.030 |
Why?
|
| Models, Economic | 1 | 2016 | 62 | 0.030 |
Why?
|
| Therapeutic Irrigation | 1 | 2016 | 75 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2016 | 157 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2016 | 117 | 0.030 |
Why?
|
| Laboratories | 1 | 2015 | 48 | 0.030 |
Why?
|
| Operating Rooms | 1 | 2015 | 138 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2015 | 287 | 0.020 |
Why?
|
| Recurrence | 1 | 2016 | 1231 | 0.020 |
Why?
|
| Sick Sinus Syndrome | 1 | 2012 | 9 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2012 | 3115 | 0.020 |
Why?
|
| Contraindications | 1 | 2012 | 70 | 0.020 |
Why?
|
| Patient Selection | 1 | 2016 | 708 | 0.020 |
Why?
|
| Death, Sudden | 1 | 2012 | 43 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 2042 | 0.020 |
Why?
|
| Biopsy | 1 | 2016 | 1210 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 1931 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 1741 | 0.020 |
Why?
|
| Disease Progression | 1 | 2016 | 1561 | 0.020 |
Why?
|
| Ranolazine | 1 | 2010 | 4 | 0.020 |
Why?
|
| Contrast Media | 1 | 2016 | 1097 | 0.020 |
Why?
|
| Registries | 2 | 2006 | 998 | 0.020 |
Why?
|
| Verapamil | 1 | 2010 | 34 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2011 | 157 | 0.020 |
Why?
|
| Ventricular Dysfunction | 1 | 2010 | 28 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2014 | 502 | 0.020 |
Why?
|
| Device Removal | 1 | 2011 | 169 | 0.020 |
Why?
|
| Autistic Disorder | 1 | 2010 | 150 | 0.020 |
Why?
|
| Cardiac Output | 1 | 2009 | 159 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 3922 | 0.020 |
Why?
|
| Materials Testing | 1 | 2008 | 96 | 0.020 |
Why?
|
| Surface Properties | 1 | 2008 | 132 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 789 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2009 | 253 | 0.020 |
Why?
|
| Observer Variation | 1 | 2009 | 626 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2009 | 348 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 4690 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 983 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2009 | 936 | 0.020 |
Why?
|
| Body Surface Area | 1 | 2006 | 37 | 0.020 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2006 | 46 | 0.010 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 99 | 0.010 |
Why?
|
| United States | 2 | 2011 | 7785 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2006 | 116 | 0.010 |
Why?
|
| Creatinine | 1 | 2006 | 299 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 909 | 0.010 |
Why?
|
| Heart Atria | 1 | 2006 | 297 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 1018 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 1982 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2006 | 473 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 395 | 0.010 |
Why?
|
| Logistic Models | 1 | 2006 | 1273 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2006 | 1962 | 0.010 |
Why?
|
| Probability | 1 | 2001 | 365 | 0.010 |
Why?
|
| Ethanol | 1 | 2003 | 273 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 7034 | 0.010 |
Why?
|
| Adolescent | 1 | 2009 | 9878 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2001 | 2603 | 0.010 |
Why?
|